Petrazzuolo, Adriana
Perez-Lanzon, Maria
Martins, Isabelle
Liu, Peng http://orcid.org/0000-0002-1682-9222
Kepp, Oliver http://orcid.org/0000-0002-6081-9558
Minard-Colin, Véronique
Maiuri, Maria Chiara http://orcid.org/0000-0001-9760-7674
Kroemer, Guido http://orcid.org/0000-0002-9334-4405
Article History
Received: 4 March 2021
Revised: 17 June 2021
Accepted: 17 June 2021
First Online: 16 July 2021
Ethics statement
: Animal experiments were conducted in compliance with the EU Directive 63/2010 and with protocols #18967-2019020612051799v2 and #28893-2021010810535218v2 approved by the local Ethical Committee (“C. Darwin” registered at the French Ministry of Research).
: GK has been holding research contracts with Daiichi Sankyo, Glaxo Smyth Kline, Eleor, Institut Mérieux, Kaleido, Lytix Pharma, PharmaMar, Sotio, and Vasculox/Tioma. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Samsara Therapeutics and Therafast Bio. OK is a scientific co-founder of Samsara Therapeutics. VMC has been holding research contracts with Roche, Bristol Myers Squibb, and Novartis.